Upgrade to SI Premium - Free Trial

HSBC Upgrades BioNTech (BNTX) to Buy

August 2, 2024 4:02 AM
HSBC analyst Yifeng Liu upgraded BioNTech (NASDAQ: BNTX) from Hold to Buy with a price target of $101.00 (from $92.00).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades

Next Articles